TIRZEPATIDE 10MG VIAL – GENLABS

The TIRZEPATIDE 10MG VIAL by GENLABS is a cutting-edge pharmaceutical product designed to support individuals in managing type 2 diabetes and obesity. This innovative medication combines the potency of Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, with the convenience of bacteriostatic water for reconstitution. GENLABS ensures the highest standards of quality, safety, and efficacy, making this product a trusted choice for healthcare professionals and patients alike.

Key Features:

1. Active Ingredient: Tirzepatide 10mg
   • Tirzepatide is a novel, once-weekly injectable medication that works by mimicking the effects of natural incretin hormones, GIP and GLP-1. These hormones play a crucial role in regulating blood sugar levels, appetite, and body weight.
   • By activating both GIP and GLP-1 receptors, Tirzepatide enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety, leading to improved glycemic control and weight management.
2. Bacteriostatic Water Included:
   • Each vial comes with bacteriostatic water, which contains 0.9% benzyl alcohol as a preservative. This ensures the sterility and stability of the reconstituted solution, allowing for multiple doses to be drawn from a single vial over time.
   • The inclusion of bacteriostatic water simplifies the reconstitution process, making it convenient for both healthcare providers and patients.
3. High-Quality Manufacturing:
   • GENLABS is committed to delivering pharmaceutical-grade products manufactured in state-of-the-art facilities that comply with Good Manufacturing Practices (GMP).
   • Rigorous quality control measures are implemented at every stage of production to ensure the purity, potency, and safety of the product.
4. Indications:
   • Type 2 Diabetes Management: Tirzepatide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
   • Weight Management: It is also used for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity.
5. Dosage and Administration:
   • The recommended starting dose is 2.5 mg once weekly, with gradual titration to 5 mg, 10 mg, or 15 mg based on individual patient response and tolerability.
   • The medication is administered subcutaneously in the abdomen, thigh, or upper arm. Proper injection techniques should be followed to ensure optimal results.
6. Safety and Side Effects:
   • Tirzepatide is generally well-tolerated, but like all medications, it may cause side effects. Common side effects include nausea, vomiting, diarrhea, decreased appetite, and constipation.
   • Patients should be monitored for signs of hypoglycemia, especially when used in combination with other glucose-lowering agents.
   • Contraindications include a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
7. Storage and Stability:
   • Store the unopened vial in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
   • Once reconstituted, the solution should be used within a specified period (as indicated in the product insert) and stored at room temperature or refrigerated, protected from light.
8. Packaging:
   • Each package contains one 10mg vial of Tirzepatide and one vial of bacteriostatic water.
   • The product is packaged in a secure, tamper-evident container to ensure integrity during transport and storage.

Why Choose GENLABS TIRZEPATIDE 10MG VIAL?

• Proven Efficacy: Clinical trials have demonstrated significant reductions in HbA1c levels and body weight, making Tirzepatide a powerful tool in diabetes and obesity management.
• Patient Convenience: The once-weekly dosing regimen improves adherence and reduces the burden of daily medication.
• Trusted Brand: GENLABS is a reputable pharmaceutical company known for its commitment to innovation, quality, and patient care.

Conclusion:
The TIRZEPATIDE 10MG VIAL (WITH BACTERIOSTATIC WATER) by GENLABS represents a breakthrough in the treatment of type 2 diabetes and obesity. With its dual-action mechanism, high-quality formulation, and patient-friendly design, this product offers a comprehensive solution for improving glycemic control and promoting weight loss. Trust GENLABS to provide a reliable and effective medication that meets the highest standards of pharmaceutical excellence.